Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO Subscriptions PDA Services My JCO Customer Service

Journal of Clinical Oncology, Vol 22, No 8 (April 15), 2004: pp. 1510-1517
© 2004 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2004.03.103

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davis, M. P.
Right arrow Articles by LeGrand, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davis, M. P.
Right arrow Articles by LeGrand, S. B.
Related Articles
Right arrowRelated Correspondence

REVIEW ARTICLE

Appetite and Cancer-Associated Anorexia: A Review

Mellar P. Davis, Robert Dreicer, Declan Walsh, Ruth Lagman, Susan B. LeGrand

From the Harry R. Horvitz Center for Palliative Medicine, Department of Hematology/Medical Oncology; the Cleveland Clinic Foundation, and the Cleveland Clinic Taussig Cancer Center Cleveland, OH

Address reprint requests to Mellar P. Davis, MD, FCCP, Cleveland Clinic Foundation, 9500 Euclid Ave, R35, Cleveland, OH 44195; e-mail: davism6{at}ccf.org

Appetite is governed by peripheral hormones and central neurotransmitters that act on the arcuate nucleus of the hypothalamus and nucleus tactus solitarius of the brainstem. Cancer anorexia appears to be the result of an imbalance between neuropeptide-Y and pro-opiomelanocortin signals favoring pro-opiomelanocortin. Many of the appetite stimulants redress this imbalance. Most of our understanding of appetite neurophysiology and tumor-associated anorexia is derived from animals and has not been verified in humans. There have been few clinical trials and very little translational research on anorexia despite its prevalence in cancer.

A WHO project in palliative medicine.

Authors' disclosures of potential conflicts of interest are found at the end of this article.


Related Correspondence

  • Serotonin and Cancer Anorexia: Myths or Facts?
    A. Laviano, F. Rossi Fanelli, and M.M. Meguid
    JCO 2005 23: 2111-2112 [Full Text]


This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
D J Harrington, H Western, C Seton-Jones, S Rangarajan, T Beynon, and M J Shearer
A study of the prevalence of vitamin K deficiency in patients with cancer referred to a hospital palliative care team and its association with abnormal haemostasis
J. Clin. Pathol., April 1, 2008; 61(4): 537 - 540.
[Abstract] [Full Text] [PDF]


Home page
Palliat MedHome page
L. Radbruch, F. Strasser, F. Elsner, J. F. Goncalves, J. Loge, S. Kaasa, F. Nauck, P. Stone, and the Research Steering Committee of the European As
Fatigue in palliative care patients -- an EAPC approach
Palliative Medicine, January 1, 2008; 22(1): 13 - 32.
[Abstract] [PDF]


Home page
JCOHome page
C. Ma and A. Jatoi
Wine for Appetite Loss: "How Do You Know?"
J. Clin. Oncol., April 1, 2007; 25(10): 1285 - 1287.
[Full Text] [PDF]


Home page
Palliat MedHome page
J. E Shragge, W. V Wismer, K. L Olson, and V. E Baracos
The management of anorexia by patients with advanced cancer: a critical review of the literature.
Palliative Medicine, September 1, 2006; 20(6): 623 - 629.
[Abstract] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. E Morley, D. R Thomas, and M.-M. G Wilson
Cachexia: pathophysiology and clinical relevance.
Am. J. Clinical Nutrition, April 1, 2006; 83(4): 735 - 743.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
D. A. Reardon and P. Y. Wen
Therapeutic advances in the treatment of glioblastoma: rationale and potential role of targeted agents.
Oncologist, February 1, 2006; 11(2): 152 - 164.
[Abstract] [Full Text] [PDF]


Home page
Palliat MedHome page
A. Wilcock
Anorexia: a taste of things to come?
Palliative Medicine, January 1, 2006; 20(1): 43 - 45.
[PDF]


Home page
JCOHome page
T. Yavuzsen, M. P. Davis, D. Walsh, S. LeGrand, and R. Lagman
Systematic Review of the Treatment of Cancer-Associated Anorexia and Weight Loss
J. Clin. Oncol., November 20, 2005; 23(33): 8500 - 8511.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
J.N. Gordon, S.R. Green, and P.M. Goggin
Cancer cachexia
QJM, November 1, 2005; 98(11): 779 - 788.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
T. W. Mattox
Treatment of Unintentional Weight Loss in Patients With Cancer
Nutr Clin Pract, August 1, 2005; 20(4): 400 - 410.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
F. A. de Jong, F. K. Engels, R. H.J. Mathijssen, L. van Zuylen, J. Verweij, R. P.H. Peters, and A. Sparreboom
Medicinal Cannabis in Oncology Practice: Still a Bridge Too Far?
J. Clin. Oncol., May 1, 2005; 23(13): 2886 - 2891.
[Full Text] [PDF]


Home page
JCOHome page
A. Laviano, F. R. Fanelli, and M.M. Meguid
Serotonin and Cancer Anorexia: Myths or Facts?
J. Clin. Oncol., March 20, 2005; 23(9): 2111 - 2112.
[Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 Site Map

Copyright © 2004 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online